- ISIN
- US98956P1021
- CUSIP
- 98956P102
- Sector
- Healthcare
- Industry
- Medical Devices
- IPO Date
- Jul 25, 2001
Highlights
- Market Cap
- $17.05B
- Enterprise Value
- $25.27B
- EPS (TTM)
- $3.85
- PE Ratio
- 22.62
- PEG Ratio
- 0.33
- Total Revenue (TTM)
- $8.41B
- Gross Profit (TTM)
- $5.89B
- EBITDA (TTM)
- $2.21B
- Year Range
- $79.12 - $108.29
- Target Price
- $102.88
- ROA (TTM)
- 3.35%
- ROE (TTM)
- 5.17%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
ZBH Performance Chart
Zimmer Biomet Holdings, Inc. (ZBH) is down 2.9% since the beginning of the year. At $87 per share, ZBH is trading 19.6% below its 52-week high of $108. Investors who bought $1,000 worth of ZBH shares 5 years ago would now be looking at an investment worth $569.
Loading charts...
Returns By Period
Zimmer Biomet Holdings, Inc. (ZBH) has returned -2.88% so far this year and -3.53% over the past 12 months. Over the last ten years, ZBH has returned -1.82% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
Zimmer Biomet Holdings, Inc.
- 1D
- -1.00%
- 1M
- 1.86%
- YTD
- -2.88%
- 6M
- -2.50%
- 1Y
- -3.53%
- 3Y*
- -14.72%
- 5Y*
- -10.67%
- 10Y*
- -1.82%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
ZBH Monthly Returns History
Based on dividend-adjusted daily data since Jul 25, 2001, ZBH's average daily return is +0.04%, while the average monthly return is +0.68%. At this rate, an investment would double in approximately 8.5 years.
Historically, 52% of months were positive and 48% were negative. The best month was Apr 2009 with a return of +20.5%, while the worst month was Oct 2008 at -28.1%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 6 months.
On a daily basis, ZBH closed higher 51% of trading days. The best single day was Mar 24, 2020 with a return of +15.6%, while the worst single day was Nov 5, 2025 at -15.2%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -3.17% | 13.06% | -7.90% | -8.84% | -0.12% | 5.78% | -2.88% | ||||||
| 2025 | 3.64% | -4.71% | 8.73% | -8.95% | -10.56% | -0.78% | 0.48% | 15.77% | -6.94% | 2.09% | -3.02% | -7.55% | -14.03% |
| 2024 | 3.20% | -0.99% | 6.33% | -8.86% | -4.27% | -5.54% | 2.60% | 3.69% | -6.30% | -0.95% | 4.84% | -5.56% | -12.46% |
| 2023 | -0.13% | -2.72% | 4.50% | 7.15% | -8.02% | 14.53% | -5.12% | -13.77% | -5.59% | -6.96% | 11.40% | 4.84% | -3.81% |
| 2022 | -3.16% | 3.39% | 3.77% | -5.59% | -0.45% | -12.41% | 5.07% | -3.69% | -1.44% | 8.42% | 5.96% | 6.36% | 4.24% |
| 2021 | -0.27% | 6.11% | -1.68% | 10.67% | -4.98% | -4.32% | 1.62% | -7.94% | -2.56% | -2.21% | -16.43% | 6.42% | -17.02% |
Benchmark Metrics
Zimmer Biomet Holdings, Inc. has an annualized alpha of 1.91%, beta of 0.75, and R2 of 0.26 versus S&P 500 Index. Calculated based on daily prices since July 25, 2001.
- This stock participated in 87.93% of S&P 500 Index downside but only 76.28% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.26 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 1.91%
- Beta
- 0.75
- R²
- 0.26
- Upside Capture
- 76.28%
- Downside Capture
- 87.93%
Return for Risk
Risk / Return Rank
ZBH ranks 36 for risk / return — below 36% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Zimmer Biomet Holdings, Inc. (ZBH) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ZBH | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.15 | ||
| Sortino ratioReturn per unit of downside risk | -2.70 | ||
| Omega ratioGain probability vs. loss probability | 1.01 | 1.37 | -0.36 |
| Calmar ratioReturn relative to maximum drawdown | -0.14 | 2.78 | -2.92 |
| Martin ratioReturn relative to average drawdown | -0.27 | 12.44 | -12.71 |
Dividends
Dividend History
Zimmer Biomet Holdings, Inc. provided a 1.10% dividend yield over the last twelve months, with an annual payout of $0.96 per share. The company has been increasing its dividends for 13 consecutive years.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.96 | $0.96 | $0.96 | $0.96 | $0.96 | $0.93 | $0.93 | $0.93 | $0.93 | $0.93 | $0.93 | $0.85 |
Dividend yield | 1.10% | 1.07% | 0.91% | 0.79% | 0.75% | 0.76% | 0.62% | 0.64% | 0.93% | 0.80% | 0.93% | 0.86% |
Monthly Dividends
The table displays the monthly dividend distributions for Zimmer Biomet Holdings, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.00 | $0.24 | ||||||
| 2025 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.24 | $0.96 |
| 2024 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.24 | $0.96 |
| 2023 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.24 | $0.96 |
| 2022 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.24 | $0.96 |
| 2021 | $0.00 | $0.00 | $0.23 | $0.00 | $0.00 | $0.23 | $0.00 | $0.00 | $0.23 | $0.00 | $0.00 | $0.23 | $0.93 |
Dividend Yield & Payout
Dividend Yield
Zimmer Biomet Holdings, Inc. has a dividend yield of 1.10%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
Zimmer Biomet Holdings, Inc. has a payout ratio of 25.00%, which is below the market average. This means Zimmer Biomet Holdings, Inc. returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Zimmer Biomet Holdings, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Zimmer Biomet Holdings, Inc. was 65.03%, occurring on Mar 9, 2009. Recovery took 1182 trading sessions.
The current Zimmer Biomet Holdings, Inc. drawdown is 47.62%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
Financial crisis2007–2009 | -65.03%Mar 2009 | 1y 10mo | 4y 8mo | 6y 6moApr 2007 - Nov 2013 |
2026 bear market2026 | -52.14%May 2026 | 5y 12d | — | 5y 1moApr 2021 - now |
COVID crash2020 | -49.73%Mar 2020 | 29d | 9mo 24d | 10mo 23dFeb 2020 - Jan 2021 |
2006 bear market2006 | -40.49%Jul 2006 | 2y 12d | 9mo 1d | 2y 9moJul 2004 - Apr 2007 |
2016 bear market2016 | -26.23%Nov 2016 | 3mo 6d | 8mo 2d | 11mo 8dAug 2016 - Jul 2017 |
Drawdown Indicators
| ZBH | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -65.03% | -56.78% | -8.25% |
Max Drawdown (1Y)Largest decline over 1 year | -25.54% | -9.10% | -16.44% |
Max Drawdown (3Y)Largest decline over 3 years | -43.94% | -18.90% | -25.04% |
Max Drawdown (5Y)Largest decline over 5 years | -48.53% | -25.43% | -23.10% |
Max Drawdown (10Y)Largest decline over 10 years | -52.14% | -33.92% | -18.22% |
Current DrawdownCurrent decline from peak | -47.62% | -1.80% | -45.82% |
Average DrawdownAverage peak-to-trough decline | -20.10% | -10.71% | -9.39% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.27% | 2.03% | +11.24% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Zimmer Biomet Holdings, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Zimmer Biomet Holdings, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for ZBH, comparing it with other companies in the Medical Devices industry. Currently, ZBH has a P/E ratio of 22.6. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for ZBH compared to other companies in the Medical Devices industry. ZBH currently has a PEG ratio of 0.3. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ZBH relative to other companies in the Medical Devices industry. Currently, ZBH has a P/S ratio of 2.0. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ZBH in comparison with other companies in the Medical Devices industry. Currently, ZBH has a P/B value of 1.2. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with ZBH
Add Zimmer Biomet Holdings, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with ZBH